Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
Condition(s):Thyroid CancerLast Updated:August 15, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Thyroid CancerLast Updated:August 15, 2018Completed
Condition(s):Thyroid CancerLast Updated:November 15, 2023Active, not recruiting
Condition(s):Differentiated Thyroid CancerLast Updated:August 28, 2019Terminated
Condition(s):Thyroid CancerLast Updated:October 31, 2023Recruiting
Condition(s):Thyroid NeoplasmsLast Updated:August 17, 2016Recruiting
Condition(s):Thyroid Cancer; Thyroid NoduleLast Updated:January 30, 2020Unknown status
Condition(s):Thyroid CancerLast Updated:June 16, 2021Completed
Condition(s):Galactin 3-thyroid CarcinomaLast Updated:January 27, 2023Not yet recruiting
Condition(s):Thyroid Nodule; Thyroid Neoplasms; Thyroid CancerLast Updated:March 29, 2016Completed
Condition(s):Thyroid NeoplasmLast Updated:May 12, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.